| AC | Abdominal circumference |
| AIDS | Acquired immunodeficiency syndrome |
| ART | Antiretroviral therapy |
| Av | Average |
| BIC | Bictegravir |
| CD4 | Cluster of differentiation 4 co-receptor for the T-cell receptor |
| CDC | Centers for Disease Control and Prevention |
| CRP | C-reactive protein |
| CVR | Cardiovascular risk |
| D:A:D® | Data Collection on Adverse Events of Anti-HIV Drugs Study |
| EACS | European AIDS Clinical Society |
| EAPC | European Association of Preventive Cardiology |
| DOR | Doravirine |
| DLG | Dolutegravir |
| GPPAQ | General Practice Physical Activity Questionnaire |
| HT | Hypertension |
| HDL | High-density lipoprotein cholesterol |
| HIV | Human immunodeficiency virus |
| HIV-RNA | Test of HIV ribonucleic acid |
| IL-6 | Interleukin-6 |
| LDL | Low-density lipoprotein cholesterol |
| MetS | Metabolic syndrome |
| NRTI | Nucleoside reverse transcriptase inhibitors |
| OR | Odd ratio |
| PLWH | People living with HIV/AIDS |
| SCORE2 | Systematic Coronary Risk Evaluation 2 |
| SD | Standard deviation |
| UNAIDS | Joint United Nations Programme on HIV/AIDS |
| WBC | White blood cell |
| WHO | World Health Organization |